5th Clusterin/Apolipoprotein (CLU) Workshop

*Poster layout guideline:

The size of the poster should be maximum: 110 cm wide and 120cm high

Poster Session
Abstr. No	Presenting author name and poster title
P 01.	Eirini Balantinou: MULTIPLE LEVELS OF CLUSTERIN REGULATION FOLLOWING PROTEASOME AND LYSOSOME INHIBITION IN NORMAL AND CANCER HUMAN CELLS. Molecular & Cellular Aging Laboratory, Institute of Biological Research & Biotechnology, National Hellenic Research Foundation, Athens, Greece. Email: ebalantin@eie.gr
P 02.	Sonia Blanco-Prieto: CLUSTERIN AS A POSSIBLE BIOMARKER FOR COLORECTAL CARCINOMA. A PROTEOMIC STUDY ON Caco-2 CELL LINE AND HUMAN TISSUE. Department of Biochemistry, Genetics and Immunology; University of Vigo. E-mail: soniabp@uvigo.es
P 03.	Eva M. Goetz: THE REGULATION OF THE IGF-1-sCLU PATHWAY AFTER IONIZING RADIATION IN CANCER. Simmons Comprehensive Cancer Center, Program in Cell Stress and Cancer Nanomedicine, University of Texas Southwestern Medical Center at Dallas, TX. E-mail: eva.goetz@utsouthwestern.edu
P 04.	Seok-Woo Hong: CLUSTERIN AS A REGULATOR OF PANCREAS REGENERATION. Department of Anatomy and Center for Advanced Medical Education by BK 21 project, College of Medicine, Inha University, Shinheung-Dong, Jung-Gu, Incheon, 400-103, Korea. E-mail: sunpark@inha.ac.kr
P 05.	Paola Mazzarelli : CLUSTERIN AND FATTY ACID SYNTHASE: MOLECULAR FOCUS ON A COMPLEX CROSS-TALK. Lab. of Molecular Pathology, Dept. of Biopathology, University of Rome Tor Vergata, 00133, Rome, Italy. E-mail: paola.mazzarelli@uniroma2.it
P 06.	Davide Pellacani: POSSIBLE CLUSTERIN EFFECTS IN THE MODULATION OF NF-kB SIGNAL PATHWAY IN THE PROSTATE GLAND. Dipartimento di Scienze Biomediche, Universita' di Modena e Reggio Emilia, Via G. Campi 287-41100 Modena, Italy. E-mail: davide.pellacani@gmail.com
P 07.	Maximino Redondo: ANTICLUSTERIN TREATMENT OF BREAST CANCER CELLS INCREASES THE SENSITIVITIES OF CHEMOTHERAPY AND TAMOXIFEN AND COUNTERACTS THE INHIBITORY ACTION OF DEXAMETHASONE ON CHEMOTHERAPY-INDUCED CYTOTOXICITY. Department of Biochemistry, Hospital Costa del Sol, Carretera de Cádiz Km 187, 29600 Marbella, Málaga, Spain. E-mail: mredondo@hcs.es
P 08.	Maria J. Roldán: CLUSTERIN EXPRESSION IS MODULATED BY PROMOTOR METHYLATION IN HUMAN CARCINOMAS. Department of Biochemistry, Hospital Costa del Sol, Carretera de Cádiz Km 187, 29600 Marbella, Málaga, Spain. E-mail: mjroldancardenete@hotmail.com
P 09.	Göran Ronquist: AUTOANTIBODIES AGAINST CLUSTERIN IN PROSTATE CANCER PATIENTS. Department of Medical Science, University Hospital, Uppsala, Sweden, E-mail: Goran.ronquist@medsci.uu.se
P 10.	David Stejskal: THE DETERMINATION OF SERUM AND CEREBROSPINAL FLUID CLUSTERINE UTILIZED IN THE DIAGNOSTICS OF THE CNS AFFECTION – A PILOT STUDY. Department of Laboratory Medicine, Sternberk Hospital, Jivavská 20, 785 16 Sternberk, Czech Republic. E-mail: david.stejskal@nemstbk.cz
P 11.	Kalliopi Thanopoulou: STUDY OF THE ROLE OF APOLIPOPROTEIN J IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE IN A TRANSGENIC MOUSE MODEL. Laboratory of Cellular Neurobiology, Centre of Basic Research I, Biomedical Research Foundation of the Academy of Athens. E-mail: kaliterra@hotmail.com